Tissue Regenix Group expands manufacturing capacity in San Antonio

The announcement has been made to the stock exchange.The announcement has been made to the stock exchange.
The announcement has been made to the stock exchange.
The regenerative medical devices company Tissue Regenix has started to expand its manufacturing base in the US as demand for its products grows.

Tissue Regenix Group has announced, that following the recent completion of its fundraising, the company has started the first phase of its planned manufacturing capacity expansion programme in San Antonio, which represents a key element of the group's commercial development plan.

The first phase is expected to take around six months to complete and will include the development of operational capabilities in the new 21,000 sq ft building to house freezers and distribution functions that will free up space for additional sterile packaging clean rooms to be built in the existing facility.

Hide Ad
Hide Ad